He obviously knew of the increased mortality of Onglyza, so he dumped the entire diabetes franchise. Well played pisano!
He's not that bright. The company knew we couldn't be competitive so we dumped the whole diabetes business. Remember it was sold at a loss. He was also the guy who bought amylin
As a stockholder, I'm glad he has been CEO. I understand reps that post here are smarter than Lamberto.